Lucid Diagnostics, a medical diagnostics company specializing in cancer prevention, has announced the launch of the next generation of its…
Browsing: Hot headlines in GI
Researchers from the Francis Crick Institute and Aalborg University in Copenhagen have made a significant breakthrough in the early detection…
In a significant development for colorectal cancer treatment, Takeda has successfully obtained FDA approval for Fruzaqla, a VEGF inhibitor, as…
The World Health Organization (WHO) has recently published a set of important regulatory considerations for the use of artificial intelligence…
A recent peer-reviewed study published in Nature Communications introduces MSIntuit™ CRC, an innovative AI-driven digital pathology diagnostic tool developed by…
Many physicians are seriously considering their practical options for a career that has nothing to do with clinical work. Perhaps…
llumina, a genomics company, has announced the launch of a new generation of its liquid biopsy assay, TruSight Oncology 500…
The recent updates finalized by the Centers for Medicare & Medicaid Services (CMS) to its physician fee schedule for 2024…
The Medscape article titled “MASLD, MASH Projected to Grow by 23% in the US Through 2050” discusses a study predicting…
This approval is specifically for patients who have undergone prior treatments including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, anti-VEGF therapy, and,…